In short
EUVC Podcast Episode Summary
Episode Title
Matti Hautsalo, Nordic Science Investments: University Spin-outs, Multidisciplinary Bets & The Playbook to Scale Science in Europe
Hosts
- Andreas Munk Holm
- David Cruz e Silva
Guest
- Matti Hautsalo, Founding Partner at Nordic Science Investments (NSI)
---
Episode Overview In this episode, Andreas Munk Holm interviews Matti Hautsalo, who discusses the unique challenges and opportunities of investing in university spin-outs in Europe. Nordic Science Investments focuses on early-stage funding for science-powered companies, especially those emerging from universities. The conversation delves into innovative strategies for team building, attracting CEOs, and navigating the complex landscape of tech transfer offices (TTOs).
---
Key Concepts and Discussions
- The Shift in Spin-out Opportunities
- Emerging Potential: Great companies can arise from researchers if the technology and commercial leadership are established early.
- Dynamic Duo Model: Emphasizes the importance of having both a scientific founder and a commercial leader in the team.
- The Role of a Dedicated Spin-out Fund
- Bridging the Gap: Traditional VCs often overlook university spin-outs due to strict criteria. NSI aims to provide initial private capital to bridge this "Death Valley" of funding.
- Collaboration with Tech Transfer Offices (TTOs)
- Navigating Ownership: Insights on the negotiation process with TTOs and best practices for ownership stakes.
- Resource Allocation: Discussions around how TTOs can be resource-constrained, impacting spin-out success.
- Building Effective Teams
- Interim vs. Permanent Leadership: Strategies for selecting interim CEOs and the importance of setting expectations from the start.
- Attracting Talent: Offering meaningful equity and a credible follow-on plan to lure industry leaders.
- Structuring Incentives
- Cap Table Management: Importance of creating a balanced cap table and avoiding over-allocation to non-operating senior academics.
- Vesting Structures: Standard cliff and linear vesting practices to retain talent.
- The Multidisciplinary Approach
- Value of Cross-Disciplinary Ventures: The best spin-outs often come from collaborations across different scientific disciplines, which are frequently overlooked by traditional investors.
- Case Study - Perfect Technologies: An example of a company merging physics and food science to innovate butter alternatives.
- Investment Strategy and Ticket Sizes
- Pre-Seed and Seed Funding: Typical investment sizes around €100k for pre-seed and €500k for seed, with flexibility based on specific cases.
- Milestone-Based Funding: Emphasis on achieving specific tech and commercial milestones before advancing to larger funding rounds.
- Ecosystem and Stakeholders
- Importance of Other VCs: Collaboration with other investors to create a supportive ecosystem for deep tech.
- Pan-European Expansion: The need for more specialized funds across Europe to scale university spin-outs effectively.
---
Key Takeaways
- University spin-outs present significant funding opportunities, particularly in the deep tech sector, but require specialized knowledge and strategies.
- Successful spin-outs depend on strong leadership teams comprising both scientific and commercial expertise.
- Collaboration with TTOs is crucial, yet challenging; navigating these relationships can make or break a spin-out's success.
- A multidisciplinary approach can yield innovative solutions that traditional silos often miss.
---
Conclusion Matti Hautsalo emphasizes the need for a focused approach to fund university spin-outs effectively, advocating for deeper engagement with TTOs and fostering multidisciplinary collaborations. NSI aims to not only provide capital but also the necessary support to help scientific innovations reach their commercial potential.
For further insights, listeners are encouraged to follow the EUVC podcast for ongoing discussions about European venture capital.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:00Welcome back friends to yet another episode of the EAVC podcast. Today I'm excited to introduce you to Mati Houtsalo. It's always interesting when I try and talk to Finnish and Estonian guys, because my English is not good at any way getting me close to being able to pronounce your names, but I think I got it somewhere right, didn't I? You got it totally right, man. Thank you. You're a founding partner at Nordic Science Investments, and you're of course leading your OCH investing into university spin-outs and you're helping build science-powered teams, bridging disciplines beyond conventional silos and fostering rich networks outside of VC to support deep tech founders that come, of course, especially from the university ecosystems.
0:39You've just closed the first fund, which is a 60 million fund. And it's, of course, dedicated to academic innovation and to real companies. Before we start the show, a quick note. If you're building or running a fund, you know it takes the right partners. At EUVC, we only work with sponsors we truly believe should be part of your tech stack. Please do take a moment to hear about them. And if you do, reach out, mention EUVC. It's the best way you can support what we do. Thank you so much. Starting off, HSBC Innovation Banking. If you're a founder, a scale-up, or a VC, you need a bank that actually understands your world.
1:12HSBC Innovation Banking backs innovation globally, from seed to IPO. And if you ask me, a strong banking partner like HSBC belongs in your stack. If your portfolio companies are scaling, they need infrastructure that won't slow them down. Google Cloud Starter Program offers$2 ,000 to$350 ,000 in credits, plus technical support to build better and faster. It's a key boost every fund should bring into their ecosystem and oh my God, are we thankful to be partnering with them. Now, legal is a space you cannot lag on. Legal needs to move at the speed of venture. Goodwin's team has decades of experience with startups and funds.
1:49They're trusted at every stage from formation to exit. Goodwin definitely is a legal partner every series manager should have in their stack. For Luxembourg-based VC, PE and fund-of-fund managers, modern funds means going digital. Fundcrafts gives you a full service, digital native platform built for today's European managers. It's a must have if you're scaling smart. So we all hear about the Middle East. How about you go there? From AI to deep tech to summer funds, Gaitex in Dubai is where global future of tech gets negotiated. It's not just a conference. It's where East meets West, capital meets innovation, and the bulls set the agenda.
2:24If you're playing on the global stage, join us going to Gaitex this year. If you're gearing up for your next fundraiser and want a placement agent who truly understands emerging managers, reach out to CFunds, their boutique placement agency that has helped GPs across Europe raise capital from top tier LPs. We've been on the other side of the table here. They are actually good ones to work with. So I do urge you to go to CFunds.io to go and check them out. And hey, before you go, if you're looking to discover startups, raise capital, connect with innovation leaders, do check out dealflow.eu, the EU-backed platform, bridging founders, VCs, and corporates.
2:57There's no better place to find the startups that have received significant funding from the European innovation ecosystem.
3:22This show is not investment advice and the hosts of this episode may be invested in the funds and companies featured. So tell me, Mati, where did you come from to end up doing this? Right. So we have a very diverse team who come from different parts of life. In a nutshell, in our founding partners, we have tech transfer, we have a researcher background, we have a founder background, we have a VC background, and we have an investment banking background. So that's one of the main themes of our team. We try to be diverse as being a venture capitalist team. And this is something that we're looking for in our portfolio companies.
4:03the diversity as early as possible as well. Myself, my background is originally from consulting and asset management, jumping into the other end of the investment nearly 20 years ago, what was then called deep tech and raising finance for some companies and then joining a Finnish VC, being there for eight years, seven of them as a partner and did already our university-based startups, had them under my belt. And some of them went well and some of them didn't go well. But already that time I learned about this field and the fact that it's been a really lucrative area for investment, both for the LPs and for the university ecosystems in the UK and United States.
4:49So we wanted to embark on this one. And then in the between, I was managing a private investment company where we exactly did spinouts from North America, UK and Finland, which were more or less in the overlapping areas of AI and deep computation and biology and very much as sort of co-founder stage, all academic backgrounds. And it's a special field and we feel that it's underserviced in the continental Europe, definitely in the north of Europe. Masi, conventional VC wisdom back in the days was you never ever want to invest in a founder that comes directly out of university or from a research background.
5:31That has changed a lot, especially as we, of course, seen the dawn of deep tech and the more importance on having very verticalized, specialized knowledge. Can you talk a bit about that shift and what made you bullish enough to do a university spin-out focused fund? Yeah, absolutely. Thanks. So one of the things, of course, is what we look at is the potential technology. And this relates to the team building, which we will probably touch upon a little bit later. The technology as such and the innovation is the crucial thing in the beginning. In the long run, of course, everyone knows it's execution, execution, execution.
6:12But in the beginning, you have to have the core around which to build. And you actually do have to have a solid tech science person slash team to do that around. Something that we have noticed is that there are the exceptions that you can have a researcher making a great executive. In most of the cases, it's not the case, but you can have a researcher making a great key person in the team, for instance, the CSO or CTO. And that's something that we've been doing a lot, like bringing in the commercial expertise after our investment, if you believe in the concept. You're saying something there that also is super against conventional wisdom, so to say.
6:55Conventional VC wisdom would say you want to back a founder that can go all the way. And I only love founder-led companies, even at the public stage. It should be the founders, not someone hired in. Talk a bit about why you're contrarian on that. Well, one thing that we're seeing, for instance, in a lot of life science related companies is that what you need is a it's often a sort of a dynamic duo. It can be more, but it's often a combination of the tech and science and the business and commercial acumen. It's not so much about the titles. We have in our portfolio examples of companies where the founder is actually still the CEO and there's an excellent CBO doing the fundraising and the business relations.
7:41And we have cases where the founder is the CTO, CSO, and we found a great guy coming from outside to become the CEO at a very early stage compared to that new CEO's background and daring to take the leap because of the promise of the technology. But if you get these two persons to work together, then going to the next finance round later on where there are other investors in addition to Nordic Science Investments or NSI, as we call it, then that's so much easier. But having just the business when you have a company based on science, that doesn't work either. What's the value in having a university spin-out focused firm?
8:25Why isn't it enough that we have deep tech investors that just automatically, so to say, will realize what's happening out of the universities and the best will surface to them? Well, one of the reasons is actually what you pointed out in your previous question. I've been on the sort of traditional side of the table as a traditional VC. And it's exactly because they don't, science-empowered spinouts, don't tick all the boxes for the traditional VCs. for instance in relation to the team and the potential is sort of left there on the shelf of the university the IPR stays there if they don't get to spin out so the death valley is even bigger for science cases than for sort of more traditional deep tech cases and if they get actually the first investment the first private money after spinning out that's really crucial the statistics are pretty powerful for those science pinouts actually in both in switzerland and uk you have plenty of statistics showing that 90 of these companies if they get the first private funding they are up and running after five years which is totally the coppers uh opposite of the of the traditional you know wisdom that you know in three to four to five years you know 80 percent of them are dead.
9:46Now, one can ask that, is that a good sign or a bad sign? Because, you know, are they so early that they don't even die yet during the first five years? The cool thing is that in many of the cases, there's years or even decades of research behind the company before it's spun out. So if it's sort of incubated long enough under the academic wings, they are actually quite mature in terms of the proof of concept and and the validation of the tech. What edge does it give you, Mati, that you're university focused versus all other funds that are not? One edge that we have is know-how. We have a lot of tech transfer knowledge in our team.
10:29Three of our five, six people in the team have tech transfer background. All of them also have private sector background as founder or investment banker or startup entrepreneur. But we do know how to take the IPR from the universities through the processes to the companies, how to check that all the transfer of the core knowledge and especially the core intellectual property rights is done. And that's typically something that also keeps the traditional investors a little bit nervy with the early stage spin-outs. And we hope that we can function as a sort of stamp of quality for other investors, other deep tech investors to join us soon, then on the following runs, because they said, okay, NSI was there, they've done their work, they know this part of the chain.
11:19So, you know, we can tick some of the boxes and go and join them if we believe in the company. There's a bunch of critique, if I'm very honest, of the TTOs in Europe and the universities in general, how they deal with IP, how they deal with founders. Too often it's said that they block founders rather than empower them. Can you talk a bit about both best practices when it comes to TTO work, but maybe more importantly as a VC, how do you work with them to ensure that you actually have a working relationship that empowers the founders and makes the companies work rather than get caught? Right. That's an excellent question.
12:03and we could spend half a day on this, but I'll try to be short. No, don't be short. Go long, my friend, because this is one of our ecosystem's big issues, I think. So first of all, when you look at the TTOs, I think you have to separate two things. One is the process, how they deal with the promising inventions and the spin-out processes. And the other one is the strategy, what the university takes towards the potential ownership or what the university gets back from spinning out a company. So in both senses, you get a lot of diversification, a lot of heterogeneity. Even within one country, the universities are very different from each other.
12:43In the Nordics, we've seen universities where the process is actually quite elaborated, but the strategy leaves questions, to put it politely, from the traditional investor's point of view. For instance, some of the universities being a little bit on the greedy side in terms of wanting the early stage. What is not okay just to get it out there? Somewhere around the 10 % plus minus is definitely okay. What is challenging is when it goes above 20 % or so. But then again, if you look at universities, for instance, in the UK, they have had a lot of successful spinouts with very, very heavy stake for the university in the beginning.
13:24So maybe it hasn't eased up the path for the spinout, but they've made it great anyway. So I don't think it's necessarily a crucial stop sign not to go for it. In the end of the day, it is about the tech. You know, if the promise of the invention is so large, then you're, of course, a little bit more okay to accept the largest tech for the university. Having said that, one thing that makes a difference is that some universities have actually these university-based funds that can make even pretty significant follow-on investments. So that makes a difference. They don't necessarily bring the knowledge how to take the company ahead, but they can support them financially also after this pinout.
14:08So that does make a difference as well. Have you yet, Mati, run into a case where you thought the tech was awesome and the founding team is there, but we're just being blocked from being able to do anything here because of the university? The honest answer is no, but we've come across cases where there's quite a long discussion with university tech transfer offices or the people managing the funds behind it. But that has never been the reason to stop it in the end of the day. And going back to your previous question, I think it's important to understand that, at least in the Northern Europe, I would say that the people working in the tech transfer offices, they're pretty well trained.
14:54I mean, they are not perfect like anyone, but it's more about the resources. You know, they do tend to know what they should be looking for, how to take ahead the invention disclosures into the further process, how to help with the patenting and so on and so forth. But it is that some universities have like one or two people doing this. Then there are universities like University of Helsinki, where you have over 20 people in the team. And it's a totally different ballgame, of course, to manage the process. I think the sort of level of awareness and education is pretty good. So it's the matter to find those universities where they really need your help to sort of drag them out, even before the spin-outs and talk to the promising teams before they have decided to fund the company.
15:40And the smaller universities actually need more help. You know, they get much more out of an investor like us, whereas the biggest ones, which do tend to attract also the traditional VCs at least once or twice a year to sort of check their sort of undergrowth portfolio, they need less of that help. You often hear the critique of TTOs and universities being so strong-minded that it almost sounds like, I've definitely seen a lot of statements saying it's impossible to do spin-out investing in Europe because of XYZ. Is it your view that, no, if you're a VC that knows how to deal with the TTOs and knows the boundaries and the inner workings of a TTO and a university, the deal can be made.
16:33It's just a matter of knowing how to navigate it and what's going on on the other side. So in other words, if you're a VC with the right skill set, a good startup should not die inside a university. Welcome to our team, Andreas. You kind of nailed it. No, I mean, that's very much it. First of all, this is people's business. It's trust building business. The university, which we start talking to the tech transfer people and the related parties, it's not that they sort of welcome us with open arms right away. We have to explain to them how we work and start showing them with some teams that are maybe thinking of setting up a company so that we also give signals to the university how we work.
17:23And that's how you start getting the sort of deal flow also a little bit more from the sort of unofficial angles. And they start calling you. And by the way, that these guys might benefit from your sparring. You know, would you have a half an hour to chat with them and things like that. We don't want to try to change the ways the university do their stuff too early. We don't have the bandwidth. We can't start, you know, lobbying a university. Do change your strategy. It's rather sort of case driven, you know, that if we find a good case, then we start, how does this university do it? And then we find a way to do it.
18:03And we don't try to sort of change the way they do things. Maybe in the long run, some of them, they are asking our advice and comments on when they're developing their spin-out strategies and ownership strategies. And that's great, but we adapt ourselves to each of the universities, how they work. And that takes time. And that's one of our, I think it's one of our challenges. This is a labor intensive way of deal sourcing and doing it. So we have a, compared to the size of our fund, we have a quite a large team. We have to be there on the campuses.
18:56Now, let's shift to founder and team building, because I at least remember from back in my days, I was actually with a government-backed fund that was targeting specifically deep tech spin outs from universities. And one of the constant discussions that we had inside the team was, can this founder become CEO material? Can we find someone who can be a co-founder with a stronger commercial mindset? And honestly, back in the days, I didn't make it to see clearly whether it can be done or cannot be done. There are definitely some that are clearly on the spectrum of, no, you cannot go and find a co-founder.
19:40It needs to be a fully set team before we interact. And then there are others that say, no, if you want to do this type of work, this type of investing, you got to pull up your sleeves and actually or roll up your sleeves and actually do the work of helping form the founding team. Yeah, there are two standard cases. One is that we know and actually the team knows or acknowledges that they don't have the CEO inside the team. Then the question is that do they have an interim candidate to do that until we find the CEO together with them? And let's get back to how to attract the CEOs soon. But then there are cases where you clearly have a promising person in the team or attracted by the university already that there's someone in Finland they call often commercial champions.
20:33And some of them are better, some of them are less good, but some of them definitely can take the company out and to be the CEO for the first 12 months, 24 months maybe even. And it's really important basically just to sort of be open and talk with the team. What are your expectations? What is the expectation if there's an interim CEO in the beginning? You know, how long she or he is going to be in the position? Is that person willing to be there for the long run, which we typically hope in another CXO position? Often those people may trade either CTOs or COOs in the long run. The truth is that in most of the cases, you do need to recruit the CEO from outside quite soon.
21:18Because we have positioned ourselves so early in the value chain, we have a bit of an advantage. We can actually say to the CEO candidates that, look, we've only invested a small pre-seed investment, but we can go on with much more significant follow-on investments. And if you come to this really promising company and take it to the right direction, will be there and will be attracting other co-investors for the follow-on rounds. So for the CEO, maybe with an industry background, maybe with a little bit of wealth already built so that he or she doesn't need 200 ,000 euros a year right away, but rather sensible salary and rather, you know, incentivization state.
21:59So he or she joins the company and understands that, yeah, it's worth taking a bit of a risk, you know, and let's see if we can really make it and if I can help them to go to the right direction during the next year, and then we can go for the follow-on rounds. We've seen cases where the teams themselves from university have tried to recruit, and it's really tough because that's where the CEO thinks that, wow, there are a lot of risks. Can you tell me a bit about the principles that you work on the basis of when you're thinking about incentivizing an incoming CEO? Again, it all starts talking with the team and if needed, getting the university tech transfer office behind it.
22:42But you start talking about the cap table really early. And this is not rocket science, but it's something that is a typical challenge that, for instance, a team has a senior researcher who will stay in academia and has been important in creating the invention, but will not commit himself or herself into the company and is going to stay in a fairly passive role in the academia. and because the team has been thinking that this is a senior person having helped a lot, let's give that person a 20 % stake or 30 % straight, which is a no-go. And, you know, in that case, we can be the sort of constructive bad cops.
23:25By the way, university tech transfer offices, they do know that this is not how you should build the cap table, but it's much easier for us to come outside as investors and say that this is not going to fly because the university tech transfer offices, they will work with these professors and researchers also in the future. So we talked to the team, we talked to the senior researcher that this is more how it should look like. And then at the same time, you build, of course, the option pool for the future CEOs, future CXOs, key recruitments to be incentivized. So we quite typically, we enter there at some sort of a 20 % option pool ready for the first key person recruitment, who is quite often a CEO.
24:09Can you talk a bit about the core terms of that type of hiring that are really important to get right and where you see people going wrong? The core terms is first that before that hiring process starts, the founder team accepts. We talk it through with them, what it means in practice. And we also talk about vesting, which of course applies to the founders as well. And it's a lot of sort of sparring and education really, to put it bluntly. then it's you know in some cases they are they are so promising that you can you can get the first recruitment the ceo with a little bit lower stake and lower option pool but but it all really boils down into the number the the share of equity offered to the ceo that's i there are other things of course to be thought of but that's really the main thing how how to build the cap table and and with the right enough enough pool for the early ceo joining the company from outside How do you think about, because a notorious problem is that researchers, when they realize what it takes to actually be a founder, they realize maybe my life as a researcher was a bit better.
25:25And for that reason, you have researchers running for the hills after a year or two. How do you work with this? How do you ensure that doesn't happen? And how do you protect, from a terms perspective again, against that scenario? vesting is one obvious thing and you have to be transparent someone returning during the first 12 months you know that's that's you know it's it's standard stuff that there's a cliff for for 12 months and that's what we typically have and after that the vesting goes linear in linear manner and we're kind of in this sense we're sort of teaching them the the VC way from the very beginning it's important that the cap table is sort of for the commitment, it's not for rewarding what happened in the past in creating the invention or the and that's often the most difficult discussion to have.
26:20Then of course the people, it's a soft skill but you can see that you know some of them actually from very early stage they start running towards the goal and you're not really worried about the motivation. What you are worried about is the actual performance and the execution. But the motivation, that is actually very soon to be seen. And it tends to be so that those who are not motivated, they don't jump into the spin outside in the first place. Matti, I'd love to shift topic or focus of this conversation to investing beyond silos, so to say, because one of the things that you're very bullish around is multidisciplinary cases, where you're seeing two or multiple fields coming together.
27:06Right. So this is what we call in a sort of branding manner as well. They are the hidden gems for us and for everyone. And this is actually one of the sections which is even more underserviced than the rest of the science-empowered companies. Investors, for all the good reasons that we know and very solid reasons, tend to be very focused on the silos that they understand. We all know why that is. Now, especially when you talk about cases stemming from basic science, some of the most transformative ones are really, and this is not just BS, it's actually, you know, the real out-of-the-box thinking.
27:48It's like people from two faculties, very different faculties talking to each other and, you know, sharing what they know. And there's maybe some pretty standard stuff, but can be applied in your other field or the other way around? And some of the best cases come from there and someone needs to dare to be there. And that's one of our main theses, that you have to dare to be there in the multidisciplinary cases. I'll give you an example. Our very first investment was Perfect Technologies, which is it is a food tech company, which is actually coming from the physics department, material physics department.
28:24So they use ultrasound to manipulate plant oils in such a way that you get the consistency, the structure and taste of butter, but you get nearly 0 % of saturated fats. No plant oils, no coconut oils, very, very, very green technology at the same time. Where did it come from? It wasn't just the physics guys. There was a top guy, research-wise from the food biology side from a different faculty of the same university and and he was a top guy in in olio gels which is which are these gels around with which which which they use in their products and this is a great example the food food tech investors which by the way is a very hammered area validation wise at the moment you know they would look at oh it's material physics stuff and what about the scaling and and it's it's actually a powerful but a a bit complex patent portfolio created there.
29:20And they are sort of not necessarily looking at it because it's not a traditional one. And then sort of physics or say material sciences investors look at, oh, it's food tech. Not for us. No, no, no. And I think that's a classic example. Now, we have actually closed around just a small series A round with Perfat just a couple of weeks ago. And we did get some food tech investors from Central Europe to join us. And I think that's a prime example where you can then attract others after us stepping in. And I think we will need the food tech guys in the portfolio and as the owners, co-owners for us to take the company ahead.
Read the full transcript
30:00So I'm really excited about it. It's going to the right direction, but it's a classic example that was a little bit hard to grasp. Mati, I seem to recall something with the way that universities are built now and the way you built your career as a researcher or professor in a university. Being multidisciplinary is very difficult and you're having a harder and harder time finding researchers that go from two or span more than one area. Am I right in saying that there's something structural there in how our universities work and how you progress in your career as a researcher that is limiting the number of breakthrough innovations across disciplines?
30:50If you look at the pure researchers, yes, there's more and more this sort of very siloed approach and the physics researcher not being really able to assess another physics researcher's field because they are so specialized. At the same time, I think that thanks to AI, partly, you know, there is much more sort of crossbreeding across segments. And some universities are actually encouraging these multidisciplinary things. There's one program in Finland at the moment, it's interdisciplinary research openings, right? Great word. But they are actually encouraging truly interdisciplinary teams with quite strong funding to set up research projects.
31:36projects. And I think there is maybe some awareness building in also in the universities that some of the biggest breakthroughs may come this way. And one shouldn't be sort of too strict on this matter anyway. I mean, think of Dennis Hassabis. He won the Nobel Chemistry Prize, but he's a super mathematician, but he started off coding games and having being great at that one as well. So it's like one wouldn't have guessed that he becomes the Nobel laureate of chemistry one day. This is one of my favorite stories when people tend to think of scientific disciplines like being extremely restricted.
32:17Matti, I'd love to ask you a bit about how do you allocate as a VC across the stages? Is it even more radical when it comes to the detrenched investments than other fields when you're doing university spin-ups? I would say that, and I'm being brutally honest here, one of the things we do is that when we do the pre-seeds, which are quite small investments, we do set up milestones for the companies. Typically, it's like one tech milestone and one commercial milestone, and they are not very complex ones. The pre-seeds don't take the companies years ahead. You have to show things quite quickly. Now in the Nordics there are there's a lot of soft funding to help to sort of match the pre-seed funding with but you have to be pretty simple with the milestones and not to have too complex ones and quite often at least it seems that in our portfolio we have made good choices, the companies are performing very well and quite a few of them seem to be sort of qualifying for the seed round where we typically already take other investors with us and co-investors.
33:28And then the real difficult thing is, I would say, it's from the seed to the Series A where you have to do a lot of filtering already and you have to be very disciplined. But then already at that stage, it's much more traditional VC game. And if I'm simplifying a little bit, I would say that our approach is that we break the rules from the seat onwards, we are like other VCs in terms of our criteria. Yeah, which I think is actually a very good way to state it. You got to get from this fussy, messy front end of this type of investment into getting into really good shape from a pure VC perspective, because otherwise you're going to have a huge financial risk on the company.
34:13Right, right. And we have also been quite honest to many of our founders. I've said to them that in a sense, if we believe in the potential of technology, we really start doing our DD from inside after we do the pre-seed. And of course, because of the fun mathematics, we do quite a lot of pre-seeds compared to our fund size. So we don't take board seats at that stage typically. But of course, we sort of do the DD from inside and we spar them. And especially with the CXO attraction that we do along with the team, even though we don't have the board seat in the early stage. Talk a bit about your ticket sizes in the pre-seed and auto-seed.
34:57So the pre-seed is typically sort of 100k plus minus. And then the seed is around half a million in euros. And of course, every case is different. I mean, this is what you show to the LPs when you raise funds, that this is the columns and that's what to do. But we have done cases which are halfway there, like the first entries between the 100 and 500k. So, of course, you have to look at it in practice on case by case basis. But that's the typical what we say. I am sure you get a bunch of pushback on that 100k. At least as I recall or remember, a lot of founders in this space, they're like, guys, we've spent$3 million already developing the science.
35:43And now you're coming with$100K. What can I do with your$100K? Give me a million or we're not doing this. Yeah. So a typical example is that they have enough. Of course, every founder rather raises more than less. And that's the right thing to do. But what you can actually do with that is to build the runway. And I dare to say we are not being very greedy with the 100K. We can go with as an equity or via convertible with the typical discounts. And, you know, it's really for them to get some more validation. And in many of the cases, you know, actually with the 100K, they can go pretty, I mean, not far, but show that they are a company.
36:30it also with many of the cases you have some pilot programs you know with industry and they want to do that rather with a spin-out company and with a commercial entity rather than with a university research group so doing the 100k there and another 100k through public funding soft funding they actually get to do the start the pilot programs and i actually get the black and white in terms of contractual matters and that does matter it's it's it's heading the way for the the actual seed run. Okay, now I want to ask you a final question before we close, and that's a bit about the ecosystem around these companies.
37:07Who are the key players? So obviously the universities and TTOs are absolutely essential, but what are the other important stakeholders in this type of investing? Meaning, can you map out the ecosystem in a little bit for me? One of the important thing is actually other VCs, definitely. You don't need to educate them on deep tech. They know they're tough that's that's for sure but but on the on the sort of path what is needed to sort of uh get to their radar and to show show success early not necessarily exit success because you can't show that early typically of course but uh but that the the industry traction is there at an early stage for those companies and i think there is a sort of there will be a sort of a snowball effect when the sort of afraidness or VCs being a little bit scared over the science pinouts, when that will start going away.
38:04And that has happened in UK, which has much more history in this field and which is much more saturated in terms of the VCs, by the way. So I think that in Europe, UK is the only saturated market in terms of funding supply. The continental Europe is way behind. The other thing is, of course, it's scaling. We should do this pan-European. You know, there should be like 100 other NSIs in Europe. And this is a broader topic, but we should get Europe up and running. And it's not a fast thing, but some of the fundamental things come from this segment of science. Many of the games we've lost already to US and China in the existing broad markets.
38:48So this is the way to sort of bring Europe back up again. And I think this links to things that you and I have, for instance, taught, how the European players in general see this. The pension funds should be investing in deep tech, in VCs. They have a tiny little allocation there only. And it's not just, of course, science-based VCs, but all VCs. and it is a matter of bringing the new growth, which takes years, but you have to start from somewhere. And this is one great way to start it. We should be talking more to big family offices who are maybe interested in certain technologies because of their background and how to ramp up their way to the deep tech in their product development and product building.
39:36And that's certainly one of the areas where the ecosystem needs to be more ambitious which we should be looking at also larger size probably, not just small funds in the early stage, but funds that do this more broadly in the pan-European sense. While you were talking, I was just researching a bit here, trying to find what other funds do we have in Europe that do a similar type of thing that you do, meaning dedicated to university spin out. Of course, you have the EU-backed entities of the ICE fund and the USME fund and so on, all of these programs. I think we all know them. There are pros and cons and so on.
40:21Then on the pure private side, I'm finding companies like Photon Ventures in Netherlands. Then we've got Deep Ocean Ventures in Rome. QDNL participations in Amsterdam as well. Quanted, Helsinki, I guess you know them very well. cubic capital in Switzerland. And then I'm not finding that many more. I'm sure there are some that I'm forgetting here. I can't remember if I mentioned Early Bird's uni fund, but that's, of course, also an important one. I think that there are some more, definitely, but funds that actually work with the universities and source directly from the campuses, there's only a handful.
41:00I think there's one in Austria. there's a small fund in sort of Northwestern Spain working with three universities, but it's like 4 million or something, but like very pre-seed. What you see much more often is like you have a university related fund, which is for the pre-seed and seed tickets, but that's sort of earmarked for the university only. And we absolutely need them. And they have a great relationship to source things out of that university, but they are, you know, it's not enough. We need to have the sort of more, diverse approach, players who work with many universities, because that also, of course, brings the scale and the understanding that where you can combine things.
41:41One of the traditional challenges is that science-based pinouts, you know, they are the scientists, the founders, babies, you know. When do you dare to merge your baby with another baby? And we should be building, if possible, earlier, bigger teams, one management, but, you know, combining teams, tackling the same challenge and the potential. Yeah. I should, of course, say that the firms I mentioned were those that are clearly explicitly focused on university spin-outs only. I have myself invested in First Momentum Ventures. I'm a huge fan of the team. I think they're doing incredible work. IQ Capital, longstanding friends of ours as well.
42:20But they do other things than just university spin-outs. So that's why I made this delineation here and only mentioned a couple of names. So just in case there are people listening in thinking, Andres, why did you mention us? Well, visionaries tomorrow, every one of you, I love you. I was just talking here about the friends that are purely university focused. And we've done a couple of investments which are not exactly from the university pipeline, but they have a solid science background, no question on that. So it doesn't need to be coming out of the university tech transfer pipeline. The delineating factor or characteristic here is whether it's your core sourcing area and your like a really core expertise of yours is that you know how to take a startup out of a university, make it successful, engage with the university, and take the time because it is a different operating structure.
43:15You need to have a team that's not just reviewing deals quickly and sending them away if everything isn't perfect in the cap table or it looks like there's going to be a messy process with the TTO and so on. It really takes a specific eye to accepting that type of thing for you to be a successful university spin-out focused investor. Yeah. And it's accepting that you don't know everything very much, being humble. It's a network game because we see a lot of cases from different disciplines going out to the industry and academia with our, I dare to say, really, really good and a little bit exceptional networks in some cases that's important to find the find the party who knows the person who can give you the comment you know is this really state of the art at the moment looking at what's happening in elsewhere in the world yeah well you just explained exactly why it's so powerful to have a specialized fund thank you so much marty this was awesome i hope you're gonna really succeed with this because it is one of the big steps for us in europe if we can succeed in getting our university startups out of the university ecosystems.
44:19Thanks, Andreas, and welcome to join our next fund. Looking forward to it, brother. Excellent. Before we start the show, a quick note. If you're building or running a fund, you know it takes the right partners. At EUVC, we only work with sponsors we truly believe should be part of your tech stack. Please do take a moment to hear about them. And if you do, reach out, mention EUVC. It's the best way you can support what we do. Thank you so much. Starting off, HSB's Innovation Banking. If you're a founder, a scale-up, or a VC, you need a bank that actually understands your world. HSBC Innovation Banking backs innovation globally, from seed to IPO.
44:56And if you ask me, a strong banking partner like HSBC belongs in your stack. If your portfolio companies are scaling, they need infrastructure that won't slow them down. Google Cloud Starter Program offers$2 ,000 to$350 ,000 in credits, plus technical support to build better and faster. It's a key boost every fund should bring into their ecosystem and oh my god are we thankful to be partnering with them. Now, legal is a space you cannot lag on. Legal needs to move at the speed of venture. Goodwin's team has decades of experience with startups and funds. They're trusted at every stage from formation to exit.
45:31Goodwin definitely is a legal partner every series manager should have in their stack. For Luxembourg-based VC, PE and Fund of Fund managers, modern funds means going digital. Funcrafts gives you a full service, digital native platform built for today's European managers. It's a must have if you're scaling smart. So we all hear about the Middle East. How about you go there? From AI to deep tech to summer funds, Guy Techs in Dubai is where a global future of tech gets negotiated. It's not just a conference, it's where East meets West, capital meets innovation and the bolts set the agenda. If you're playing on the global stage, join us going to Guy Techs this year.
46:07If you're gearing up for your next fundraiser and want a placement agent who truly understands emerging managers reach out to cfunds their boutique placement agency that has helped gps across here brace capital from top tier lps we've been on the other side of the table here they are actually good ones to work with so i do urge you to go to cfunds.io to go and check them out and hey before you go if you're looking to discover startups raise capital or connect with innovation leaders do check out dealflow.eu the eu-backed platform reaching founders vcs and corporates There's no better place to find the startups that have received significant funding from the European innovation ecosystem.
From the publisher
Welcome back to another EUVC Podcast, where we explore the lessons, frameworks, and insights shaping Europe’s venture ecosystem.
Today, Andreas Munk Holm sits down with Matti Hautsalo, Founding Partner at Nordic Science Investments (NSI), a €60M early-stage fund dedicated to university spin-outs across the Nordics and Europe. With a team spanning tech transfer, research, founding, VC, and investment banking, NSI backs science-powered companies at pre-seed and seed, then helps recruit commercial leaders, navigate TTOs, and transfer IP cleanly so these companies can raise from broader deep-tech syndicates.
🎧 Here’s what’s covered
03:23 Why spin-outs now? - Conventional wisdom flipped: great companies can start with researchers — provided you build the tech + commercial duo early.
05:14 The “Dynamic Duo” model - Founder-scientist stays CSO/CTO; bring in an external CEO/CBO early. Titles are flexible, execution isn’t.
06:50 Why a dedicated spin-out fund? - Traditional VCs pass when boxes aren’t ticked (team/IP). NSI bridges the Death Valley with first private capital.
10:17 Working with TTOs - Best practices, process vs. policy, and what’s “OK” on ownership (≈10% fine; >20% gets tricky — but context matters).
12:56 Reality check - Hard negotiations happen — but good deals get done; the constraint is resourcing, not intent.
14:42 How VCs should navigate universities - It’s a people & trust business; adapt to each campus, don’t try to rewrite policy from the outside.
17:25 Team building - Two paths: (1) interim CEO from within; (2) recruit CEO fast — and set expectations from day one.
20:51 Attracting CEOs - Offer meaningful equity and a credible follow-on plan; industry operators will take risk if the tech is real.
21:27 Incentives & cap table - Set a ~20% option pool early; avoid dead equity for non-operating senior academics; educate on vesting.
23:27 Terms that fail - Over-allocating to passive contributors; unclear vesting; under-sizing option pools for key hires.
24:55 When founders return to academia - Standard 12-month cliff, then linear vesting; cap table rewards future commitment, not past papers.
26:39 Beyond silos = alpha - Why the best spin-outs are multidisciplinary — and why most investors miss them.
28:10 Case: Perfect Technologies - Physics × food science; ultrasound-structured oils mimicking butter at ~0% saturated fats; small Series A just closed with food-tech co-investors.
32:51 Tranching & milestones—Pre-seed is small and milestone-based (one tech + one commercial); Nordics soft funding extends runway.
35:37 Ticket sizes - ~€100k pre-seed, ~€500k seed (case-by-case); “From seed onwards we act like any other VC.”
44:58 Why specialization wins - Networks to validate state-of-the-art, patience with TTOs, and willingness to roll up sleeves on team building.




